Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2005 Dec;36(12):2637-41.
doi: 10.1161/01.STR.0000189721.31432.26. Epub 2005 Nov 3.

Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia

Marieke van Oijen  1 , Jacqueline C Witteman, Albert Hofman, Peter J Koudstaal, Monique M B Breteler
Affiliations
Randomized Controlled Trial

Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia

Marieke van Oijen et al. Stroke. 2005 Dec.

Abstract

Background and purpose: Vascular and inflammatory factors may play an important role in the pathogenesis of dementia. Studies reported an association between plasma levels of inflammation markers and the risk of dementia. Both fibrinogen and C-reactive protein are considered inflammatory markers. Fibrinogen also has important hemostatic properties. We investigated the association of fibrinogen and C-reactive protein with dementia.

Methods: The study was based on the prospective population-based Rotterdam Study. Fibrinogen was measured in a random sample of 2835 persons. High-sensitivity C-reactive protein was measured in the total cohort of 6713 persons. We identified 395 incident dementia cases during follow-up (mean, 5.7 years). We estimated the associations of fibrinogen and C-reactive protein with dementia using Cox proportional hazard models.

Results: Persons with higher levels of fibrinogen had an increased risk of dementia. The hazard ratio for dementia per SD increase of fibrinogen was 1.26 (95% CI, 1.11 to 1.44), adjusted for age and gender, and 1.30 (95% CI, 1.13 to 1.50) after additional adjustment for cardiovascular factors and stroke. For Alzheimer disease, the adjusted hazard ratio was 1.25 (95% CI, 1.04 to 1.49), and for vascular dementia it was 1.76 (95% CI, 1.34 to 2.30). High levels of C-reactive protein were not associated with an increased risk of dementia.

Conclusions: High fibrinogen levels were associated with an increased risk of both Alzheimer disease and vascular dementia, but levels of C-reactive protein were not. This suggests that the increased risk of dementia associated with fibrinogen is because of the hemostatic rather than the inflammatory properties of fibrinogen.

PubMed Disclaimer

Similar articles

  • High plasma estradiol interacts with diabetes on risk of dementia in older postmenopausal women.
    Carcaillon L, Brailly-Tabard S, Ancelin ML, Rouaud O, Dartigues JF, Guiochon-Mantel A, Scarabin PY. Carcaillon L, et al. Neurology. 2014 Feb 11;82(6):504-11. doi: 10.1212/WNL.0000000000000107. Epub 2014 Jan 29. Neurology. 2014. PMID: 24477111
  • Inflammatory proteins in plasma and the risk of dementia: the rotterdam study.
    Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, van Swieten JC, Stijnen T, Hofman A, Witteman JC, Breteler MM. Engelhart MJ, et al. Arch Neurol. 2004 May;61(5):668-72. doi: 10.1001/archneur.61.5.668. Arch Neurol. 2004. PMID: 15148142
  • Is sticky blood bad for the brain?: Hemostatic and inflammatory systems and dementia in the Caerphilly Prospective Study.
    Gallacher J, Bayer A, Lowe G, Fish M, Pickering J, Pedro S, Dunstan F, White J, Yarnell J, Ben-Shlomo Y. Gallacher J, et al. Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):599-604. doi: 10.1161/ATVBAHA.109.197368. Epub 2009 Dec 3. Arterioscler Thromb Vasc Biol. 2010. PMID: 19965782
  • Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
    Fibrinogen Studies Collaboration; Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB, Wilson AC, Folsom AR, Wu K, Benderly M, Goldbourt U, Willeit J, Kiechl S, Yarnell JW, Sweetnam PM, Elwood PC, Cushman M, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Haverkate F, de Maat MP, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi R, Vahtera E, Jousilahti P, Pekkanen J, D'Agostino R, Kannel WB, Wilson PW, Tofler G, Arocha-Piñango CL, Rodriguez-Larralde A, Nagy E, Mijares M, Espinosa R, Rodriquez-Roa E, Ryder E, Diez-Ewald MP, Campos G, Fernandez V, Torres E, Marchioli R, Valagussa F, Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Cremer P, Nagel D, Curb JD, Rodriguez B, Yano K, Salonen JT, Nyyssönen K, Tuomainen TP, Hedblad B, Lind P, Loewel H, Koenig W, Meade TW, Cooper JA, De Stavola B, Knottenbelt C, Miller GJ, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Kitamura A, Naito Y, Palosuo T, Ducimetiere P, Amouyel P, Arveiler D, Evans AE, Ferrieres J, Juhan-Vague I, Bingham A, Schulte H, Assmann G, Cantin B, Lamarche B, Després JP, Dagenais GR, Tunstall-Pedoe H, Woodward M, Ben-Shlomo Y, Davey Smith G, Palmieri V, Yeh JL, Rudnicka A, Ridker P, Rodeghiero F, Tosetto A, Shephe… See abstract for full author list ➔ Fibrinogen Studies Collaboration, et al. JAMA. 2005 Oct 12;294(14):1799-809. doi: 10.1001/jama.294.14.1799. JAMA. 2005. PMID: 16219884
  • Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
    Morange PE, Bickel C, Nicaud V, Schnabel R, Rupprecht HJ, Peetz D, Lackner KJ, Cambien F, Blankenberg S, Tiret L; AtheroGene Investigators. Morange PE, et al. Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2793-9. doi: 10.1161/01.ATV.0000249406.92992.0d. Epub 2006 Oct 5. Arterioscler Thromb Vasc Biol. 2006. PMID: 17023678
See all similar articles

Cited by

See all "Cited by" articles

Publication types